Eagle Pharmaceuticals, Inc. (EGRX)

Last Year

30-Apr-23 -- 29-Apr-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drugs - Generic

Drugs

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

18

0

1

+1

0

+2

0

+3

Two Year Chart

30-Apr-22 -- 29-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
29-Feb-24 8:23 PM View:	27-Feb-24 Payment of Exercise ($10.23K)	Cahill Brian Joseph Chief Financial Officer		Eagle Pharmaceuticals, Inc. - EGRX	0% 47.87K to 47.96K	0	0	--	--	Show Txns Hide Txns

31-Oct-23 5:41 PM View:	27-Oct-23 Option Exercise $46.24K	Graves Michael Interim Executive Chair & PEO Director		Eagle Pharmaceuticals, Inc. - EGRX	936% 1.0K to 10.36K	0	0	--	--	Show Txns Hide Txns

01-Mar-24 4:40 PM View:	28-Feb-24 Payment of Exercise ($13.29K)	Tarriff Scott 10% Owner		Eagle Pharmaceuticals, Inc. - EGRX	(11%) 1.64M to 1.45M	0	0	--	--	Show Txns Hide Txns